Seeing Is Believing
Currently out of the existing stock ratings of John Boris, 27 are a BUY (90%), 3 are a HOLD (10%).
Analyst John Boris, carries an average stock price target met ratio of 64.44% that have a potential upside of 42.96% achieved within 672 days. Previously, John Boris worked at ROTH.
John Boris’s has documented 58 price targets and ratings displayed on 10 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on AMRX, Amneal Pharmaceuticals, Common Stock at 11-Jul-2019.
Analyst best performing recommendations are on AMRX (AMNEAL PHARMACEUTICALS, COMMON STOCK).
The best stock recommendation documented was for AMRX (AMNEAL PHARMACEUTICALS, COMMON STOCK) at 12/18/2018. The price target of $13 was fulfilled within 27 days with a profit of $2.91 (18.29%) receiving and performance score of 6.77.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$13
$0.48 (3.83%)
$11
1 months 16 days ago
(31-Oct-2025)
9/10 (90%)
$2.18 (20.15%)
524
Buy
$14
$1.48 (11.82%)
$12
3 months 1 days ago
(16-Sep-2025)
3/4 (75%)
$4.26 (43.74%)
116
Buy
$11
$-1.52 (-12.14%)
$10
9 months 14 days ago
(03-Mar-2025)
9/9 (100%)
$2.24 (25.57%)
580
Buy
$8
$-4.52 (-36.10%)
$6.25
1 years 7 months 11 days ago
(06-May-2024)
6/6 (100%)
$1.35 (20.30%)
106
Buy
$7
$-5.52 (-44.09%)
$6
2 years 1 months 9 days ago
(08-Nov-2023)
4/4 (100%)
$2.94 (72.41%)
150
What Year was the first public recommendation made by John Boris?